Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Shilpa Medicare Ltd - 530549 - Announcement Under Regulation 30

 This is to inform you that the Pharmaceutical Research & Development Unit of the Company situated at Modavalasa, Vizianagaram (Dt), Andhra Pradesh region has received U.S FDA Establishment Inspection Report (EIR) with intimation of closure of inspection on 08 Apr 2019. This R&D; site has undergone an inspection by the USFDA during 11 Feb 2019 to 13 Feb 2019, wherein we were issued a Form 483 with 1 (one) observation. Based on our responses and follow up actions, the USFDA has determined the inspection classification of this facility as Voluntary Action Initiated (VAI). This is for your information and doing the needful.
20-04-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Shareholding for the Period Ended March 31, 2019

 Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
20-04-2019
Bigul

Shilpa Medicare Ltd - 530549 - Compliance Certificate For The Period Ended 31/03/2019

 With reference to the subject cited above, please find attached herewith the Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, issued by the Company and the RTA i.e. M/s. Karvy Fintech Private Limited.
19-04-2019
Bigul

Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Resignation of Director

 With reference to the above-cited subject, we wish to inform you that Mr. Ajeet Singh Karan (DIN: 00183622), an Independent Director of the Board of the Company, has submitted his resignation which has been accepted with effect from 15th April, 2019 due to his preoccupation i.e. he is starting his own venture. He has been on the Board since 28th January, 2011. This is for your information and record.
15-04-2019
Bigul

Shilpa Medicare Ltd - 530549 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- SUSHIL BAJAJDesignation :- Authorised Signatory
12-04-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Intimation Under Regulation 30 Of SEBI(LODR)Regulations.

 This is to inform you that the Company has received U.S. Food and Drug Administration tentative approval for its ANDA, Bortezomid for Injection, 3.5mg/vial on 08.04.2019
09-04-2019
Bigul

Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 With reference to the captioned subject, Please be noted that Mr. Madhusudhan Reddy, Company Secretary and Compliance officer of Shilpa Medicare Limited has at the Board of Directors Meeting Held on 1st April, 2019 tendered his resignation letter. The same has been accepted by the Board and he has been relieved w.e.f. 04th April, 2019. In the intermittent period of filing up of vacancy, Mr. Sushil Bajaj, Chief Financial Officer and Key Managerial Personnel of the company would be acting as the Compliance officer of the Company.
04-04-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window

 The board of directors of shilpa medicare limited have declared the closure of trading window from 01/04/2019 till 48 hours from the conclusion of the board meeting in which the financials for Year ended 31/03/2019 would be approved
01-04-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Outcome of Board Meeting

 The Board of Directors meeting of Shilpa Medicare Limited at their meeting held on 01/04/2019 approved the transactions as enclosed herewith inter-alia other transactions
01-04-2019
Bigul

SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramakant Inani
01-03-2019
Next Page
Close

Let's Open Free Demat Account